Virology: Seeking solutions to viral migration

July 3, 2013
Virology: Seeking solutions to viral migration
Cultured cells (green) normally vulnerable to infection by chikungunya virus (red; left) acquire additional antiviral resistance after being genetically modified to produce the protein viperin (right). Credit: 2013 A*STAR Singapore Immunology Network

Although seldom fatal, persistent infection by chikungunya virus (CHIKV) afflicts patients with joint pain lasting months or even years. This insect-borne virus has received relatively little scientific attention in the 50 years since its initial description in African patients, but researchers in Singapore have now uncovered a host protein that can keep CHIKV in check.

"Globalization and have lent a helping hand in the resurgence of CHIKV, such that a virus originally from Africa and mosquitoes originally from Asia [could] meet in the Indian Ocean and spread to other parts of the world," explains Preston Teng, a researcher in Lisa F. P. Ng's laboratory, part of the A*STAR Singapore Immunology Network. The expanding reach of the virus motivated Ng and her co-workers to investigate how CHIKV interacts with the immune system.

Ng's team had already established that CHIKV infection triggers cellular signaling pathways mediated by the type I interferon proteins, which activate genes involved in the antiviral 'innate' immune response. As a follow-up, the team searched for specific activated in collected from 24 CHIKV patients. Their analysis revealed a sharp, viral load-dependent increase in the activity of the gene encoding the protein viperin, which is involved in the to numerous viruses.

Ng and co-workers showed that forced production of viperin conferred additional protection against infection upon a human cell line normally susceptible to CHIKV (see image). Conversely, genetically modified mice lacking viperin were prone to heavier viral loads following CHIKV infection, resulting in more severe inflammatory symptoms.

Viperin thwarts different viruses by distinct mechanisms, so the researchers carved the protein into pieces to identify which segment acts against CHIKV. Unexpectedly, they found that viperin's anti-CHIKV activity resides almost entirely within a single helical segment of the protein. "We were intrigued to find that a short, 42-amino acid fragment of viperin was sufficient to inhibit CHIKV infection and replication effectively," says Teng.

This domain helps to localize viperin to a specific cellular compartment known as the endoplasmic reticulum (ER), which contributes to the production of both host and viral proteins in infected cells. The researchers propose that viperin is capable of triggering a 'stress response' in the ER that effectively shuts down production of key viral components. This process could be exploited to bolster patient defenses against CHIKV. In future research, Ng, Teng and colleagues plan to uncover the specific antiviral mechanism of this viperin domain.

Explore further: Exploiting the early immune response in Chikungunya fever promises to provide protection

More information: Teng, T.-S., et al. Viperin restricts chikungunya virus replication and pathology. The Journal of Clinical Investigation 122, 4447–4460 (2012). www.jci.org/articles/view/63120

Related Stories

Exploiting the early immune response in Chikungunya fever promises to provide protection

July 4, 2012
(Medical Xpress) -- Chikungunya fever is a viral disease that has re-emerged to cause epidemics in the Pacific region within the last decade. It is caused by the Chikungunya virus (CHIKV), which is transmitted by mosquitoes ...

Breakthroughs in Chikugunya research spell new hope for better treatment and protection

March 14, 2012
Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease. Working in close collaborations ...

Hijacked antiviral protein subverts energy production to aid viral infection

May 3, 2011
(Medical Xpress) -- Viruses are notorious for entering cells, taking over their internal machinery, and turning them into virus manufacturing centers. But new research by Howard Hughes Medical Institute investigator Peter ...

Promising new method for next-generation live-attenuated viral vaccines against Chikungunya virus

February 21, 2013
Researchers have successfully applied a novel method of vaccine creation for Chikungunya virus (CHIKV) using a technique called large scale random codon re-encoding. Using this approach, a group from the UMR_D 190, Emerging ...

Research deciphers HIV attack plan

April 1, 2013
(Medical Xpress)—A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS. The viruses that successfully ...

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.